$OPK
OPKO HEALTH, INC. Stock $opk

$opk Overview Financials Valuation SEC Filings Company Website

2019 Q3 Form 10-Q Financial Statement

#000094480919000055 Filed on August 07, 2019

Income Statement

Concept	2019 Q3	2019 Q2	2018 Q2
Revenue	$228.8M	$226.4M	$263.7M
YoY Change	-8.42%	-14.15%	-9.88%
Cost Of Revenue	$141.9M	$144.2M	$150.1M
YoY Change	-6.03%	-3.93%	4.31%
Gross Profit	$86.90M	$82.10M	$113.6M
YoY Change	-12.13%	-27.73%	-23.6%
Gross Profit Margin	37.99%	36.27%	43.08%
Selling, General & Admin	$80.54M	$88.48M	$87.65M
YoY Change	-4.2%	0.94%	-16.98%
% of Gross Profit	92.68%	107.76%	77.16%
Research & Development	$30.02M	$28.29M	$29.21M
YoY Change	-0.47%	-3.17%	-11.82%
% of Gross Profit	34.54%	34.45%	25.71%
Depreciation & Amortization	$23.81M	$23.66M	$24.76M
YoY Change	-0.48%	-4.45%	-3.09%
% of Gross Profit	27.39%	28.82%	21.8%
Operating Expenses	$267.8M	$273.6M	$268.8M
YoY Change	-5.47%	1.8%	-15.59%
Operating Profit	-$39.01M	-$47.26M	-$5.108M
YoY Change	16.58%	825.22%	-80.23%
Interest Expense	-$5.500M	-$5.300M	-$400.0K
YoY Change	77.42%	1225.0%	-109.76%
% of Operating Profit
Other Income/Expense, Net	-$20.93M	-$11.19M	$8.137M
YoY Change	439.51%	-237.53%	127.1%
Pretax Income	-$59.94M	-$58.45M	$3.029M
YoY Change	60.52%	-2029.71%	-113.61%
Income Tax	$1.769M	$1.084M	$2.017M
% Of Pretax Income			66.59%
Net Earnings	-$62.01M	-$59.81M	-$6.201M
YoY Change	124.22%	864.46%	-63.34%
Net Earnings / Revenue	-27.1%	-26.42%	-2.35%
Basic Earnings Per Share			-$0.01
Diluted Earnings Per Share	-$105.7K	-$102.0K	-$0.01
COMMON SHARES
Basic Shares Outstanding	615.6M shares	615.6M shares	559.5M shares
Diluted Shares Outstanding			559.5M shares

Balance Sheet

Concept	2019 Q3	2019 Q2	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$64.70M	$111.1M	$80.40M
YoY Change	48.05%	38.18%	-38.39%
Cash & Equivalents	$64.67M	$111.1M	$80.38M
Short-Term Investments
Other Short-Term Assets	$3.327M	$3.234M	$4.764M
YoY Change	-21.59%	-32.12%	44.93%
Inventory	$50.11M	$48.29M	$46.75M
Prepaid Expenses
Receivables	$140.8M	$148.3M	$152.8M
Other Receivables	$19.90M	$18.80M	$23.30M
Total Short-Term Assets	$292.8M	$344.2M	$321.6M
YoY Change	1.04%	7.05%	-31.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$128.5M	$137.1M	$150.2M
YoY Change	-12.8%	-8.69%	12.6%
Goodwill	$695.8M	$699.8M	$714.2M
YoY Change	-2.5%	-2.02%	0.3%
Intangibles
YoY Change
Long-Term Investments	$11.60M	$24.30M	$43.70M
YoY Change	-71.84%	-44.39%	40.97%
Other Assets	$5.528M	$3.770M	$5.246M
YoY Change	-42.73%	-28.14%	-86.6%
Total Long-Term Assets	$2.077B	$2.112B	$2.209B
YoY Change	-5.23%	-4.41%	-3.78%
TOTAL ASSETS
Total Short-Term Assets	$292.8M	$344.2M	$321.6M
Total Long-Term Assets	$2.077B	$2.112B	$2.209B
Total Assets	$2.370B	$2.456B	$2.531B
YoY Change	-4.49%	-2.95%	-8.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$77.30M	$60.38M	$69.06M
YoY Change	17.81%	-12.58%	11.11%
Accrued Expenses	$172.7M	$198.4M	$201.0M
YoY Change	-19.62%	-1.3%	-2.62%
Deferred Revenue	$30.95M	$50.39M	$61.85M
YoY Change	-49.86%	-18.53%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$10.20M	$14.30M	$40.00M
YoY Change	-75.0%	-64.25%	175.94%
Total Short-Term Liabilities	$270.1M	$283.4M	$306.9M
YoY Change	-15.01%	-7.65%	8.41%
LONG-TERM LIABILITIES
Long-Term Debt	$4.091M	$4.500M	$1.704M
YoY Change	258.23%	164.08%	9.23%
Other Long-Term Liabilities	$112.0M	$127.8M	$209.4M
YoY Change	-39.09%	-39.0%	3.77%
Total Long-Term Liabilities	$457.5M	$463.9M	$413.6M
YoY Change	22.14%	12.17%	9.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$270.1M	$283.4M	$306.9M
Total Long-Term Liabilities	$457.5M	$463.9M	$413.6M
Total Liabilities	$727.6M	$747.3M	$720.5M
YoY Change	5.09%	3.73%	8.85%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.399B	-$1.337B	-$1.081B
YoY Change	26.12%	23.61%	44.97%
Common Stock	$6.162M	$6.162M	$5.602M
YoY Change	9.96%	10.0%	0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.791M	$1.791M	$1.791M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	549.9K shares	549.9K shares	549.9K shares
Shareholders Equity	$1.642B	$1.709B	$1.811B
YoY Change
Total Liabilities & Shareholders Equity	$2.370B	$2.456B	$2.531B
YoY Change	-4.49%	-2.95%	-8.59%

Cashflow Statement

Concept	2019 Q3	2019 Q2	2018 Q2
OPERATING ACTIVITIES
Net Income	-$62.01M	-$59.81M	-$6.201M
YoY Change	124.22%	864.46%	-63.34%
Depreciation, Depletion And Amortization	$23.81M	$23.66M	$24.76M
YoY Change	-0.48%	-4.45%	-3.09%
Cash From Operating Activities	-$23.90M	-$53.60M	-$17.10M
YoY Change	9.13%	213.45%	-24.67%
INVESTING ACTIVITIES
Capital Expenditures	-$2.500M	-$3.500M	-$6.800M
YoY Change	-79.17%	-48.53%	-6.85%
Acquisitions
YoY Change
Other Investing Activities	$300.0K	$300.0K	$300.0K
YoY Change	-40.0%	0.0%	-111.11%
Cash From Investing Activities	-$2.200M	-$3.200M	-$6.600M
YoY Change	-80.87%	-51.52%	-34.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-20.00M	-39.30M	4.000M
YoY Change	566.67%	-1082.5%	-87.38%
NET CHANGE
Cash From Operating Activities	-23.90M	-53.60M	-17.10M
Cash From Investing Activities	-2.200M	-3.200M	-6.600M
Cash From Financing Activities	-20.00M	-39.30M	4.000M
Net Change In Cash	-46.10M	-96.10M	-19.70M
YoY Change	26.65%	387.82%	1870.0%
FREE CASH FLOW
Cash From Operating Activities	-$23.90M	-$53.60M	-$17.10M
Capital Expenditures	-$2.500M	-$3.500M	-$6.800M
Free Cash Flow	-$21.40M	-$50.10M	-$10.30M
YoY Change	116.16%	386.41%	-33.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Entity Central Index Key EntityCentralIndexKey	0000944809
CY2018Q4	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	11	institution
CY2018Q3	opk	Number Of Derivative Lawsuits NumberOfDerivativeLawsuits	12	lawsuit
CY2019Q2	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	0	shares
CY2019Q2	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	0	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	586881720	shares
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	616150952	shares
CY2018	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.01
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	549907	shares
CY2019Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	549907	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33528
	dei	Entity Registrant Name EntityRegistrantName	OPKO Health, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-2402409
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4400 Biscayne Blvd.
	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33137
	dei	City Area Code CityAreaCode	(305)
	dei	Local Phone Number LocalPhoneNumber	575-4100
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	OPK
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	615601045	shares
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	111115000	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	148287000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96473000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	143907000	USD
CY2019Q2	us-gaap	Inventory Net InventoryNet	48293000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	42299000	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	36533000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35052000	USD
CY2019Q2	us-gaap	Assets Current AssetsCurrent	344228000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	317731000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	137106000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	144674000	USD
CY2019Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	581306000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	614452000	USD
CY2019Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	635569000	USD
CY2018Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	635572000	USD
CY2019Q2	us-gaap	Goodwill Goodwill	699842000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	700193000	USD
CY2019Q2	us-gaap	Long Term Investments LongTermInvestments	24767000	USD
CY2018Q4	us-gaap	Long Term Investments LongTermInvestments	31228000	USD
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29640000	USD
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3770000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7222000	USD
CY2019Q2	us-gaap	Assets Assets	2456228000	USD
CY2018Q4	us-gaap	Assets Assets	2451072000	USD
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	60376000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	47395000	USD
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	198382000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	203513000	USD
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13376000	USD
CY2019Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2018Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	31562000	USD
CY2019Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	11240000	USD
CY2018Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	5851000	USD
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	283374000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	288321000	USD
CY2019Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16673000	USD
CY2019Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	206165000	USD
CY2018Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	57299000	USD
CY2019Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	113334000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	115193000	USD
CY2019Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	127751000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	198968000	USD
CY2019Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	463923000	USD
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	371460000	USD
CY2019Q2	us-gaap	Liabilities Liabilities	747297000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	659781000	USD
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	6162000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	5869000	USD
CY2019Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1791000	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1791000	USD
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3061631000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3004422000	USD
CY2019Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20351000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20131000	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1336720000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1197078000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1708931000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1791291000	USD
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2456228000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2451072000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	226368000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	263685000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	448820000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	518598000	USD
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	88475000	USD
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	87653000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	183633000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	179172000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28286000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29211000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	64816000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	62097000	USD
CY2019Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3775000	USD
CY2018Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-15358000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1031000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-13599000	USD
CY2019Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16419000	USD
CY2018Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17227000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32981000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	34498000	USD
CY2019Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	655000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	273628000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	268793000	USD
	us-gaap	Operating Expenses OperatingExpenses	571397000	USD
	us-gaap	Operating Expenses OperatingExpenses	566317000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-47260000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5108000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-122577000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-47719000	USD
CY2019Q2	opk	Interest Income Nonoperating InterestIncomeNonoperating	572000	USD
CY2018Q2	opk	Interest Income Nonoperating InterestIncomeNonoperating	27000	USD
	opk	Interest Income Nonoperating InterestIncomeNonoperating	1127000	USD
	opk	Interest Income Nonoperating InterestIncomeNonoperating	67000	USD
CY2019Q2	opk	Interest Expense Nonoperating InterestExpenseNonoperating	5501000	USD
CY2018Q2	opk	Interest Expense Nonoperating InterestExpenseNonoperating	2722000	USD
	opk	Interest Expense Nonoperating InterestExpenseNonoperating	10257000	USD
	opk	Interest Expense Nonoperating InterestExpenseNonoperating	4989000	USD
CY2019Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-388000	USD
CY2018Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	2248000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	27000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	3644000	USD
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5874000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8584000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4897000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10477000	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11191000	USD
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8137000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14000000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9199000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-58451000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3029000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-136577000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-38520000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1084000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2017000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1866000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1126000	USD
CY2019Q2	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-59535000	USD
CY2018Q2	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	1012000	USD
	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-138443000	USD
	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-39646000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9669000	USD
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-271000	USD
CY2018Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-7213000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2125000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	-59806000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	-6201000	USD
	us-gaap	Profit Loss ProfitLoss	-140568000	USD
	us-gaap	Profit Loss ProfitLoss	-49315000	USD
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	586351045	shares
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	559541253	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	586347645	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	559507732	shares
CY2019Q2	us-gaap	Profit Loss ProfitLoss	-59806000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	-6201000	USD
	us-gaap	Profit Loss ProfitLoss	-140568000	USD
	us-gaap	Profit Loss ProfitLoss	-49315000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2878000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-12465000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-220000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-7600000	USD
CY2019Q2	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	0	USD
CY2018Q2	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	0	USD
	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	0	USD
	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	4876000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-56928000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-18666000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-140788000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-61791000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1762737000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3122000	USD
CY2019Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-59806000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2878000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1708931000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1791291000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7579000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-3000	USD
CY2019Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	50852000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-140568000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-220000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1708931000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1811310000	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5578000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	318000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-6201000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-12465000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1798540000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1843623000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11514000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	318000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-49315000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-7600000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1798540000	USD
	us-gaap	Profit Loss ProfitLoss	-140568000	USD
	us-gaap	Profit Loss ProfitLoss	-49315000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	47477000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	49518000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	2868000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	2198000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	308000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	99000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2125000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9669000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7579000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	11514000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-220000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	495000	USD
	opk	Increase Decrease In Equity Securities Fvni And Derivative Instruments IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments	-5431000	USD
	opk	Increase Decrease In Equity Securities Fvni And Derivative Instruments IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments	14819000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1031000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-13599000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	655000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	168000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2026000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4398000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-12440000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6225000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-894000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2476000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3730000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-136000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	146000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	12887000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8092000	USD
	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	131000	USD
	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	-77000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-37015000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-30812000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2095000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-15820000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-102619000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-52599000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1200000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1000000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	1286000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	309000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	840000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	6432000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	12792000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7323000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11666000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	200293000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	55000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7762000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-3000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	318000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	39695000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	18817000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	78824000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	20924000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	28800000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	124599000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53211000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-15000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-64000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14642000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11118000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	96473000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	91499000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111115000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80381000	USD
	us-gaap	Interest Paid Net InterestPaidNet	785000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2132000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5251000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	29640000	USD
	us-gaap	Interest Paid Net InterestPaidNet	5411000	USD
	opk	Operating Lease Liability Initial Recognition Upon Adoption OperatingLeaseLiabilityInitialRecognitionUponAdoption	30049000	USD
	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	20000	USD
	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	806000	USD
	opk	Numberof Sales Employees NumberofSalesEmployees	300	employee
	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</span><span style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</span></div>
	us-gaap	Inventory Write Down InventoryWriteDown	1300000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	1200000	USD
CY2019Q2	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	1900000000	USD
CY2018Q4	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	2000000000.0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33000000.0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	34500000	USD
	us-gaap	Depreciation Depreciation	14500000	USD
	us-gaap	Depreciation Depreciation	15000000.0	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of credit risk and allowance for doubtful accounts</span><span style="font-family:inherit;font-size:10pt;">. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of accounts receivable. Substantially all of our accounts receivable are with either companies in the healthcare industry or patients. However, credit risk is limited due to the number of our clients as well as their dispersion across many different geographic regions.</span></div>While we have receivables due from federal and state governmental agencies, we do not believe that such receivables represent a credit risk because the related healthcare programs are funded by federal and state governments, and payment is primarily dependent upon submitting appropriate documentation.
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2100000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1800000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7600000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11500000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	24877	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	19232	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	24877	shares
	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	5645	shares
CY2018Q2	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	332000	shares
CY2018Q2	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	145677	shares
CY2018Q2	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	332000	shares
CY2018Q2	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	186323	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	332000	shares
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	145677	shares
CY2019Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	150414000	USD
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	145665000	USD
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2127000	USD
	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	332000	shares
	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	186323	shares
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1758000	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	148287000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	143907000	USD
CY2019Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	22008000	USD
CY2018Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	23264000	USD
CY2019Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	21481000	USD
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	15259000	USD
CY2019Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	3096000	USD
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2473000	USD
CY2019Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	4741000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4259000	USD
CY2019Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3033000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2956000	USD
CY2019Q2	us-gaap	Inventory Net InventoryNet	48293000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	42299000	USD
CY2019Q2	opk	Taxes Recoverable Current TaxesRecoverableCurrent	18176000	USD
CY2018Q4	opk	Taxes Recoverable Current TaxesRecoverableCurrent	15708000	USD
CY2019Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	661000	USD
CY2018Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2368000	USD
CY2019Q2	us-gaap	Supplies Supplies	10584000	USD
CY2018Q4	us-gaap	Supplies Supplies	9693000	USD
CY2019Q2	us-gaap	Prepaid Insurance PrepaidInsurance	3878000	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3436000	USD
CY2019Q2	us-gaap	Other Assets Current OtherAssetsCurrent	3234000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3847000	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	36533000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35052000	USD
CY2019Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	291649000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	258539000	USD
CY2019Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	581306000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	614452000	USD
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	50388000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	63503000	USD
CY2019Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	39453000	USD
CY2018Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	45621000	USD
CY2019Q2	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	9936000	USD
CY2018Q4	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	10401000	USD
CY2019Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5387000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2375000	USD
CY2019Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3031000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3280000	USD
CY2019Q2	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	4968000	USD
CY2018Q4	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	4871000	USD
CY2019Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3317000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7935000	USD
CY2019Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	81902000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	65527000	USD
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	198382000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	203513000	USD
CY2019Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	3665000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	27566000	USD
CY2019Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	65112000	USD
CY2018Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	105198000	USD
CY2019Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	20181000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	22162000	USD
CY2019Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4500000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4654000	USD
CY2019Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4650000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	5620000	USD
CY2019Q2	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	29643000	USD
CY2018Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	33768000	USD
CY2019Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	127751000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	198968000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	700193000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-351000	USD
CY2019Q2	us-gaap	Goodwill Goodwill	699842000	USD
CY2019Q2	opk	Equity Method Investment Excluding Variable Interest Entity EquityMethodInvestmentExcludingVariableInterestEntity	1975000	USD
CY2019Q2	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	10616000	USD
CY2019Q2	opk	Equity Method Investment Variable Interest Entity EquityMethodInvestmentVariableInterestEntity	1010000	USD
CY2019Q2	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	20856000	USD
CY2019Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	438000	USD
CY2019Q2	opk	Stock Optionand Warrant Investments StockOptionandWarrantInvestments	488000	USD
CY2019Q2	us-gaap	Long Term Investments LongTermInvestments	24767000	USD
CY2019Q2	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	183700000	USD
CY2019Q2	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	51900000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-23300000	USD
CY2019Q2	us-gaap	Equity Method Investment Quoted Market Value EquityMethodInvestmentQuotedMarketValue	12500000	USD
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-5458000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-5458000	USD
CY2019Q2	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	11	institution
CY2019Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	122479000	USD
CY2019Q2	us-gaap	Line Of Credit LineOfCredit	74041000	USD
CY2018Q4	us-gaap	Line Of Credit LineOfCredit	108710000	USD
CY2019Q2	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	20856000	USD
CY2019Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	488000	USD
CY2019Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	21408000	USD
CY2019Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	25568000	USD
CY2019Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	25568000	USD
CY2018Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	26313000	USD
CY2018Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	855000	USD
CY2018Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	27189000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	24537000	USD
CY2018Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	24537000	USD
	opk	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent	1400000	USD
CY2019Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	25600000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	24500000	USD
CY2018Q4	opk	Private Placement Agreement Sale Of Shares Shares PrivatePlacementAgreementSaleOfSharesShares	26500000	shares
CY2018Q4	opk	Private Placement Agreement Sale Of Shares Price Per Share PrivatePlacementAgreementSaleOfSharesPricePerShare	3.49
CY2018Q4	opk	Private Placement Agreement Sale Of Shares Amount PrivatePlacementAgreementSaleOfSharesAmount	92500000	USD
CY2018Q2	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	61000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	140000	USD
CY2019Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	25600000	USD
	opk	Number Of Class Action Lawsuits NumberOfClassActionLawsuits	2	lawsuit
CY2018Q4	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	100000	USD
CY2019Q2	us-gaap	Purchase Obligation PurchaseObligation	69800000	USD
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	14300000	USD
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	15700000	USD
CY2019Q2	opk	Accrued Expense Payor Overpayment Reimbursement Liability AccruedExpensePayorOverpaymentReimbursementLiability	30500000	USD
CY2018Q4	opk	Accrued Expense Payor Overpayment Reimbursement Liability AccruedExpensePayorOverpaymentReimbursementLiability	35900000	USD
CY2018Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4800000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	8500000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	91100000	USD
CY2017Q4	opk	Proceeds From Development And License Agreement Upfront Payment ProceedsFromDevelopmentAndLicenseAgreementUpfrontPayment	6000000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	USD
CY2019Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	54100000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-47260000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5108000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-122577000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-47719000	USD
CY2019Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23661000	USD
CY2018Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24762000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	47477000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	49518000	USD
CY2019Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-271000	USD
CY2018Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-7213000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2125000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-9669000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	226368000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	263685000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	448820000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	518598000	USD
CY2019Q2	us-gaap	Assets Assets	2456228000	USD
CY2018Q4	us-gaap	Assets Assets	2451072000	USD
CY2019Q2	us-gaap	Goodwill Goodwill	699842000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	700193000	USD
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29640000	USD
CY2019Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	7681000	USD
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13376000	USD
CY2019Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3031000	USD
CY2019Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16673000	USD
CY2019Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4650000	USD
CY2019Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2019Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2019Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043
CY2019Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.045
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	7968000	USD
CY2019Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	1661000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10169000	USD
CY2019Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2649000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6678000	USD
CY2019Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1938000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3754000	USD
CY2019Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	960000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2329000	USD
CY2019Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	368000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2096000	USD
CY2019Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	419000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	32994000	USD
CY2019Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7995000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2945000	USD
CY2019Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	314000	USD
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	30049000	USD
CY2019Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	7681000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	9800000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000000.0	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	1700000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	10804000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	234000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1590000	USD
	opk	Payments For Leases PaymentsForLeases	12628000	USD

Files In Submission

Name	View Source	Status
0000944809-19-000055-index-headers.html	Edgar Link	pending
0000944809-19-000055-index.html	Edgar Link	pending
0000944809-19-000055.txt	Edgar Link	pending
0000944809-19-000055-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opk-20190630.xsd	Edgar Link	pending
opk-20190630_cal.xml	Edgar Link	unprocessable
opk-20190630_def.xml	Edgar Link	unprocessable
opk-20190630_lab.xml	Edgar Link	unprocessable
opk-20190630_pre.xml	Edgar Link	unprocessable
opk-6302019x10q.htm	Edgar Link	pending
opk-6302019x10q_htm.xml	Edgar Link	completed
opk-6302019xex311.htm	Edgar Link	pending
opk-6302019xex312.htm	Edgar Link	pending
opk-6302019xex321.htm	Edgar Link	pending
opk-6302019xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPK
OPKO HEALTH, INC. Stock $opk

2019 Q3 Form 10-Q Financial Statement

#000094480919000055 Filed on August 07, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK OPKO HEALTH, INC. Stock $opk

2019 Q3 Form 10-Q Financial Statement

#000094480919000055 Filed on August 07, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK
OPKO HEALTH, INC. Stock $opk